The Victoria’s Secret Global Fund for Women’s Cancers Career Development Awards, in partnership with Pelotonia & AACR, are two-year, $206,000 grants supporting female early-stage investigators researching breast and gynecologic cancers. Apply by May 15: bit.ly/4bbh12P

Thrilled to be at the ceremony for 2024 Pezcoller–AACR Award for Extraordinary Achievement in Cancer Research recipient Titia DeLange—with Enzo Galligioni, President of the @Pezcoller; Paolo Macchi, of the University of Trento; and AACR Past President Phil Greenberg.

Additional Deadline Extension:
Submit an abstract by May 12 for the Eighth JCA-AACR Special Joint Conference on The Molecular Renaissance in Colorectal Cancer (June 28-30, Kyoto, Japan), chaired by Luis A. Diaz and Koshi Mimori. Learn more:
bit.ly/44CMgRG

Current guidelines recommend a colonoscopy every 10 years after age 45, but a new study indicates those with average risk for colorectal cancer may be able to wait 15 years between screenings. Learn more in The Week in Cancer News from Cancer Today:
bit.ly/3USEEr8

The AACR Distinguished Lectureship on Cancer Health Disparities recognizes an investigator whose work has had a major impact on the etiology, detection, diagnosis, treatment, or prevention of cancer health disparities. Nominate a colleague by May 31:
bit.ly/4dDVvFx

We stand with the AACR in recognizing National Cancer Research Month — a vital initiative that sheds light on the critical role of research in combating cancer. Learn more, and donate here: bit.ly/3URa1SM #NCRM24 #CancerResearch #EndCancer

Submit an abstract by June 18 for the Ovarian Cancer Research Symposium (September 20-21, Seattle), presented by the Rivkin Center and the AACR. Learn more:
bit.ly/4aipCiC

May is National Cancer Research Month. The AACR drives progress against cancer through Project GENIE®, an open-source, international, pancancer registry that contains 198,000 sequenced tumors from more than 172,000 patients. Learn more:
bit.ly/44z2o6R
#AACRGENIE #NCRM24

More than 5,200 individuals have been members of the AACR for more than 25 years—including 236 who have been AACR members for more than 50 years. Learn more in the AACR Annual Impact Report:
bit.ly/3JVPshN

The AACR Distinguished Lectureship in Breast Cancer Research recognizes science that has inspired, or has the potential to inspire, new perspectives on the etiology, diagnosis, treatment, or prevention of breast cancer. Nominate a colleague by May 31:
bit.ly/4drIizk

Harpreet Singh of FDA Oncology provided closing remarks for the U.S. FDA-AACR Workshop on Trial Designs for Treatment Regimens with Multiple Phases. Recordings and slides will be posted to the AACR website by May 23. bit.ly/44yTJB8 #AACRSciencePolicy

Stephanie Wethington, Naomi Horiba, Manju George, Thomas Powles, Cristina Migali, and Christine Gause discuss 'Considerations in Other Therapeutic Areas' at the FDA-AACR workshop on trial design. U.S. FDA

In the final session of the FDA-AACR workshop on Trial Design, Harpreet Singh of the U.S. FDA talks about Considerations in Other Therapeutic Areas. #AACRSciencePolicy

What is the future of multiple arm trials? Minghua Shan, Nicole Gormley, Pallavi Mishra-Lalyani, Patrick Forde, Giuseppe Giaccone, Joshua Reuss, and Kathleen Winson address this question in panel discussion at the FDA-AACR workshop. U.S. FDA @HopkinsKimmel Weill Cornell Medicine

.U.S. FDA's Bernardo Hoddock Lobo Goulart moderated a session on the Future of Registrational Trials With Multiple Arms. The session starts with a presentation by Minghua Shan of Bayer Pharmaceuticals. @Lobo_Goulart #AACRSciencePolicy

.U.S. FDA leaders participate in a Fireside Chat at the FDA-AACR Workshop on Trial Designs for Treatment Regimens with Multiple Phases. FDA Oncology #AACRSciencePolicy

A panel including Jhanelle Gray MD, Mark Yarchoan, @Vishalbmd, Jane Permutter, Fred Hirsch, @TMProwell, and Michael Axelson discusses optimizing perioperative treatment regimens at today's FDA-AACR workshop. Moffitt Cancer Center U.S. FDA Lilly The Tisch Cancer Institute Dana-Farber Johns Hopkins Kimmel Cancer Center

May is National Cancer Research Month. Thanks to research-driven advances, there are more than 18 million cancer survivors in the U.S., representing 5% of the population. Learn more in the AACR Cancer Progress Report:
bit.ly/4baLhe4
#NCRM24 #CancerResearchSavesLives

AACR Past President Elizabeth Jaffee moderates this session on Optimizing Perioperative Treatment Regimens at the FDA-AACR workshop on trial design. Jhanelle Gray MD of Moffitt Cancer Center introduces the session. #AACRSciencePolicy Dr. Elizabeth Jaffee @HopkinsKimmel

Our panel of experts discusses the landscape for perioperative trial designs: Anup Amatya, Valsamo Anagnostou, Paz Vellanki, Thelma Brown, Roy Herbst, Mark Kris, and Craig Tendler. #AACRSciencePolicy U.S. FDA @HopkinsKimmel Translational Breast Cancer Research Consortium Roy Herbst Yale Cancer Center Memorial Sloan Kettering Cancer Center